Stefansson IM - Search Results

1

Drug-sensitive FGFR2 mutations in endometrial carcinoma.

Dutt A, Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C, Nicoletti R, Winckler W, Grewal R, Hanna M, Wyhs N, Ziaugra L, Richter DJ, Trovik J, Engelsen IB, Stefansson IM, Fennell T, Cibulskis K, Zody MC, Akslen LA, Gabriel S, Wong KK, Sellers WR, Meyerson M, Greulich H. Dutt A, et al. Among authors: stefansson im. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8713-7. doi: 10.1073/pnas.0803379105. Epub 2008 Jun 13. Proc Natl Acad Sci U S A. 2008. PMID: 18552176 Free PMC article.

2

Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.

Stefansson I, Akslen LA, MacDonald N, Ryan A, Das S, Jacobs IJ, Salvesen HB. Stefansson I, et al. Clin Cancer Res. 2002 Jan;8(1):138-43. Clin Cancer Res. 2002. PMID: 11801550

3

Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma.

Salvesen HB, Stefansson I, Kalvenes MB, Das S, Akslen LA. Salvesen HB, et al. Cancer. 2002 Apr 15;94(8):2185-91. doi: 10.1002/cncr.10434. Cancer. 2002. PMID: 12001116 Free article.

4

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA. Foulkes WD, et al. Among authors: stefansson im. J Natl Cancer Inst. 2003 Oct 1;95(19):1482-5. doi: 10.1093/jnci/djg050. J Natl Cancer Inst. 2003. PMID: 14519755

5

Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.

Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA. Salvesen HB, et al. APMIS. 2003 Nov;111(11):1011-8. doi: 10.1111/j.1600-0463.2003.apm1111103.x. APMIS. 2003. PMID: 14629267

6

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA. Foulkes WD, et al. Among authors: stefansson im. Cancer Res. 2004 Feb 1;64(3):830-5. doi: 10.1158/0008-5472.can-03-2970. Cancer Res. 2004. PMID: 14871808

7

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA. Stefansson IM, et al. J Clin Oncol. 2004 Apr 1;22(7):1242-52. doi: 10.1200/JCO.2004.09.034. J Clin Oncol. 2004. PMID: 15051772

8

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.

Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Stefansson IM, et al. Histopathology. 2004 May;44(5):472-9. doi: 10.1111/j.1365-2559.2004.01882.x. Histopathology. 2004. PMID: 15139995

9

Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.

Macdonald ND, Salvesen HB, Ryan A, Malatos S, Stefansson I, Iversen OE, Akslen LA, Das S, Jacobs IJ. Macdonald ND, et al. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):957-65. doi: 10.1111/j.1048-891X.2004.014535.x. Int J Gynecol Cancer. 2004. PMID: 15361209

10

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.

Salvesen HB, Stefansson I, Kretzschmar EI, Gruber P, MacDonald ND, Ryan A, Jacobs IJ, Akslen LA, Das S. Salvesen HB, et al. Int J Oncol. 2004 Dec;25(6):1615-23. Int J Oncol. 2004. PMID: 15547698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters